(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

SLATE

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

SLATE

ST13

US500000088030324

Class

42

Filing

88030324

Registration

6775121

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

50

Latest update

06/28/2022

Trademark type

Word

Nice classes

42

Filing date

07/09/2018

Registration date

06/28/2022

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

06/28/2022

Last transaction

06/28/2022

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

09/17/2016

First use in commerce

09/17/2016

Drawing code

4

Owner type

03

Owner location

Emeryville, CA, US

Examiner

SALCIDO, JOHN CHARLES

Law office

N40

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

GRITSTONE BIO, INC.
Gritstone Oncology, Inc.

Representatives

Fidel Nwamu NWAMU PC

Technical classification

Nice Classes

Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 42

Conducting evaluations in the field of pharmaceuticals; pharmaceutical product development and evaluation services; pharmaceutical research and development; research and development of pharmaceuticals for the treatment of cancer; research and development of vaccines and medicines; technical research in the field of pharmaceutical studies; scientific research servicescollection of specific molecular and genomic data for analytical and clinical purposesfor the treatment of cancer and other diseases and disorders and for individuals' responses to drug treatments; providing scientific analysis in the field of next generation sequencing (NGS)the analysis and interpretation of genomic data obtained from cancer patients

Publications

History of USPTO decisions and trademark events.

50 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

06/28/2022

R.PR

REGISTERED-PRINCIPAL REGISTER

06/28/2022

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

05/21/2022

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

05/20/2022

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

05/20/2022

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

05/20/2022

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

05/20/2022

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

04/01/2022

GNRT

NON-FINAL ACTION E-MAILED

04/01/2022

CNRT

SU - NON-FINAL ACTION - WRITTEN

04/01/2022

SUPC

STATEMENT OF USE PROCESSING COMPLETE

03/02/2022

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

03/02/2022

IUAF

USE AMENDMENT FILED

02/08/2022

EISU

TEAS STATEMENT OF USE RECEIVED

02/08/2022

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

08/20/2021

EX3G

SOU EXTENSION 3 GRANTED

08/18/2021

EXT3

SOU EXTENSION 3 FILED

08/18/2021

EEXT

SOU TEAS EXTENSION RECEIVED

08/18/2021

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

06/23/2021

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

02/18/2021

EX2G

SOU EXTENSION 2 GRANTED

02/16/2021

EXT2

SOU EXTENSION 2 FILED

02/16/2021

EEXT

SOU TEAS EXTENSION RECEIVED

02/16/2021

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

08/05/2020

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

08/05/2020

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

08/05/2020

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

07/23/2020

EX1G

SOU EXTENSION 1 GRANTED

07/21/2020

EXT1

SOU EXTENSION 1 FILED

07/21/2020

EEXT

SOU TEAS EXTENSION RECEIVED

07/21/2020

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

02/18/2020

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

12/24/2019

PUBO

PUBLISHED FOR OPPOSITION

12/24/2019

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

12/04/2019

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

11/14/2019

RCCK

SUSPENSION CHECKED - TO ATTORNEY FOR ACTION

11/14/2019

ALIE

ASSIGNED TO LIE

11/13/2019

RCSC

REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED

04/21/2019

GNS3

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

10/09/2018

GNSL

LETTER OF SUSPENSION E-MAILED

10/09/2018

CNSL

SUSPENSION LETTER WRITTEN

10/09/2018

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

10/05/2018

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

10/04/2018

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

10/04/2018

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

08/08/2018

GNRT

NON-FINAL ACTION E-MAILED

08/08/2018

CNRT

NON-FINAL ACTION WRITTEN

08/08/2018

DOCK

ASSIGNED TO EXAMINER

08/07/2018

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

07/13/2018

NWAP

NEW APPLICATION ENTERED

07/12/2018

Continuous trademark protection

Get notified about every new filing that threatens SLATE or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.